Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Interferon-beta (IFN-beta)
DRUG
2 trials
Sponsors
EMD Serono Research & Development Institute, Inc.
, Sanofi
Conditions
Multiple Sclerosis
Multiple Sclerosis Relapse
Phase 2
A Phase 2 Study of Cladribine Add-on to Interferon-beta (IFN-beta) Therapy in Multiple Sclerosis (MS) Subjects With Active Disease (ONWARD)
Completed
NCT00436826
EMD Serono Research & Development Institute, Inc.
Multiple Sclerosis
Start: 2006-11-30
End: 2012-03-31
Updated: 2020-10-12
Phase 3
Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta
Terminated
NCT01252355
Sanofi
Multiple Sclerosis Relapse
Start: 2011-01-31
End: 2013-04-30
Updated: 2014-06-09
Related Papers
Pregnancy Outcomes During the Clinical Development Program of Cladribine in Multiple Sclerosis: An Integrated Analysis of Safety.
2020-07-01
27 citations
Cladribine tablets added to IFN-β in active relapsing MS
Neurology Neuroimmunology & Neuroinflammation
2018-07-12
60 citations
A randomized trial of teriflunomide added to glatiramer acetate in relapsing multiple sclerosis
Multiple Sclerosis Journal - Experimental Translational and Clinical
2015-09-01
7 citations